Portal de Periódicos da CAPES

Location of WES b on decay‐accelerating factor

1995; Wiley; Volume: 35; Issue: 3 Linguagem: Inglês

10.1046/j.1537-2995.1995.35395184292.x

1537-2995

Marilyn J. Telen, N A Rao, Douglas M. Lublin,

Virus-based gene therapy research

TransfusionVolume 35, Issue 3 p. 278-278 Location of WESb on decay-accelerating factor Marilyn J. Telen MD, Marilyn J. Telen MD Division of Hematology/Oncology Department of Medicine Duke University Medical Center P.O. Box 3387 Durham, NC 27710Search for more papers by this authorNeeraja Rao PhD, Neeraja Rao PhD Division of Hematology/Oncology Department of Medicine Duke University Medical Center P.O. Box 3387 Durham, NC 27710Search for more papers by this authorDouglas M. Lublin MD, PhD, Douglas M. Lublin MD, PhD Division of Laboratory Medicine Departments of Pathology and Internal Medicine Washington University School of Medicine St. Louis, MO 63110Search for more papers by this author Marilyn J. Telen MD, Marilyn J. Telen MD Division of Hematology/Oncology Department of Medicine Duke University Medical Center P.O. Box 3387 Durham, NC 27710Search for more papers by this authorNeeraja Rao PhD, Neeraja Rao PhD Division of Hematology/Oncology Department of Medicine Duke University Medical Center P.O. Box 3387 Durham, NC 27710Search for more papers by this authorDouglas M. Lublin MD, PhD, Douglas M. Lublin MD, PhD Division of Laboratory Medicine Departments of Pathology and Internal Medicine Washington University School of Medicine St. Louis, MO 63110Search for more papers by this author First published: March 1995 https://doi.org/10.1046/j.1537-2995.1995.35395184292.xCitations: 14AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF. Identification of human blood group antigens on DAF and an erythrocyte phenotype negative for DAF. J Exp Med 1988; 167: 93– 8. 2 Lublin DM, Thompson ES, Green AM, Levene C., Telen MJ. Dr(a–) polymorphism of decay accelerating factor: biochemical, functional and molecular characterization and production of allele-specific transfectants. J Clin Invest 1991; 87: 1945– 52. 3 Telen MJ, Rao N., Udani M., Thompson ES, Kaufman RM, Lublin DM. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood (in press). 4 Petty AC, Daniels GL, Anstee DJ, Tippett P.. Use of MAIEA techniques to confirm the relationship between the Cromer antigens and decay-accelerating factor and to assign provisionally antigens to the short-consensus repeats. Vox Sang 1993; 65: 309– 15. 5 Lublin DM, Mallinson G., Poole J., et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994; 84: 1276– 82. Citing Literature Volume35, Issue3March 1995Pages 278-278 ReferencesRelatedInformation